1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS

@article{Lawitz20091055AA,
  title={1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS},
  author={E. Lawitz and M. Rodr{\'i}guez-Torres and M. Demicco and T. Nguyen and E. Godofsky and J. Appleman and M. Rahimy and C. Crowley and J. Freddo},
  journal={Journal of Hepatology},
  year={2009},
  volume={50}
}
35 Citations
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
  • 1
Direct-acting antivirals for chronic hepatitis C.
  • 132
  • PDF
Hepatitis C viral kinetics: the past, present, and future.
  • 23
Hepatitis C virus-specific directly acting antiviral drugs.
  • 34
  • PDF
Hepatitis C virus: standard-of-care treatment.
  • 41
New therapeutic strategies in HCV: polymerase inhibitors
  • L. Gerber, T. Welzel, S. Zeuzem
  • Medicine
  • Liver international : official journal of the International Association for the Study of the Liver
  • 2013
  • 53
RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs.
  • Y. Waheed, A. Bhatti, Muhammad Ashraf
  • Biology, Medicine
  • Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
  • 2013
  • 21
Treatment of chronic hepatitis C: current and future.
  • J. Pawlotsky
  • Medicine
  • Current topics in microbiology and immunology
  • 2013
  • 89
...
1
2
3
4
...